Page last updated: 2024-09-05
3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Carcinoma, Lewis Lung
3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea has been researched along with Carcinoma, Lewis Lung in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lesnaia, NA; Pokrovskiĭ, VS; Romanenko, VI; Treshchalina, EM | 1 |
Other Studies
1 other study(ies) available for 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
[Pre-clinical study of combined aranosa, cisplatin and irinotecan in the treatment of experimental lung cancer].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Lewis Lung; Cisplatin; Drug Administration Schedule; Glycosides; Irinotecan; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Mice, Inbred Strains | 2009 |